Focus: Labcorp is a $12.2B public CRO and clinical diagnostics company with 70,000 employees, headquartered in Burlington, NC. It operates as a contract research and diagnostic services organization supporting pharmaceutical development and clinical testing.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Hot — 5807 jobs added in 30d
Net +3897 (5807 new, 1910 removed). Aggressive expansion phase.
4 recent layoff filings (12 mo) — 354 affected
Source: state DOL filings via Big Local News
Strong for CRO/diagnostics specialists seeking scale and stability, but recent layoffs and margin compression warrant caution on long-term security.
Help build intelligence for Labcorp
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Labcorp's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Labcorp stock holds its business focus. Clinical diagnostics remain the core. - AD HOC NEWS
Labcorp stock holds its business focus. Clinical diagnostics remain the core. AD HOC NEWS
Labcorp focuses on diagnostics and drug development as healthcare demand grows - AD HOC NEWS
Labcorp focuses on diagnostics and drug development as healthcare demand grows AD HOC NEWS
Labcorp highlights diagnostics business as investors watch long-term growth - AD HOC NEWS
Labcorp highlights diagnostics business as investors watch long-term growth AD HOC NEWS
Real-world data powers next-gen biopharma - Fierce Pharma
Real-world data powers next-gen biopharma Fierce Pharma
8-K Filing: GeneDx Holdings Corp. (WGS, WGSWW) (CIK 0001818331) — EX-99.1
EX-99.1
Labcorp Holdings (LH): Company Profile, Stock Price, News, Rankings - Fortune
Labcorp Holdings (LH): Company Profile, Stock Price, News, Rankings Fortune
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Source: state DOL filings, aggregated via Big Local News
Active restructuring poses medium-term job security risk; monitor department stability before accepting offers in affected locations.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo